Akshanth R. Polepally

Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks

Jordan J. Feld, Christophe Moreno, Roger Trinh et al. · Journal of Hepatology · 2015 · 160 citations · Full text

Drug-drug interaction profile of the all-oral anti-hepatitis C virus regimen of paritaprevir/ritonavir, ombitasvir, and dasabuvir

Rajeev Menon, Prajakta Badri, Tianli Wang et al. · Journal of Hepatology · 2015 · 125 citations · Full text

Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine

Jacob Lalezari, J. Greg Sullivan, Peter Varunok et al. · Journal of Hepatology · 2015 · 118 citations · Full text

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma

Anita D’Souza, Nina Shah, Cesar Rodriguez et al. · Journal of Clinical Oncology · 2022 · 115 citations · Full text

Model‐based lamotrigine clearance changes during pregnancy: clinical implication

Akshanth R. Polepally, Page B. Pennell, Richard C. Brundage et al. · Annals of Clinical and Translational Neurology · 2014 · 92 citations · Full text